Demo Sign up Log In

Esperion Therapeutics Inc (ESPR)

Cash Conversion Ratio

1.11×

Quarterly · Period ending: Mar 31, 2026

ESPR Cash Conversion Ratio

Latest reported1.11×period endingMar 31, 2026

Latest reported1.11×period endingMar 31, 2026

ESPR Quarterly Cash Conversion Ratio (0.96× → 1.11×)

Latest values, visible window

High-resolution chart · PNG

ESPR cash conversion ratio history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Cash Conversion Ratio — Quarterly
Period ending	Cash Conversion Ratio
Mar 31, 2026	1.1078×
Dec 31, 2025	0.7348×
Sep 30, 2025	0.1368×
Jun 30, 2025	2.4693×
Mar 31, 2025	0.5593×
Dec 31, 2024	1.6396×
Sep 30, 2024	1.2021×
Jun 30, 2024	0.1176×
Mar 31, 2024	0.8809×
Dec 31, 2023	0.6577×
Sep 30, 2023	0.4685×
Jun 30, 2023	0.4956×
Mar 31, 2023	0.8807×
Dec 31, 2022	0.7615×
Sep 30, 2022	0.7811×
Jun 30, 2022	0.7619×
Mar 31, 2022	0.6873×
Dec 31, 2021	0.8862×
Sep 30, 2021	0.9969×
Jun 30, 2021	1.0961×
Mar 31, 2021	0.9795×
Dec 31, 2020	0.6578×
Sep 30, 2020	1.0135×
Jun 30, 2020	1.1139×
Mar 31, 2020	0.8887×
Dec 31, 2019	0.8098×
Sep 30, 2019	0.8539×
Jun 30, 2019	1.0004×
Mar 31, 2019	1.0472×
Dec 31, 2018	0.4796×
Jun 30, 2001	0.963×
Mar 31, 2001	1.0107×
Dec 31, 2000	1.1317×
Sep 30, 2000	0.3331×
Jun 30, 2000	0.7501×
Mar 31, 2000	0.9614×

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.